九强生物(300406.SZ)发布上半年业绩，归母净利润1.75亿元，下降30.01%

Core Viewpoint - Jiukang Bio (300406.SZ) reported a decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company's operating revenue for the first half of 2025 was 668 million yuan, a year-on-year decrease of 18.67% [1] - The net profit attributable to shareholders of the listed company was 175 million yuan, reflecting a year-on-year decrease of 30.01% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 173 million yuan, also down 30.08% year-on-year [1] - Basic earnings per share stood at 0.3 yuan [1]